Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 992.6B, Eli Lilly(LLY) trades at $1,048.25. The stock has a price-to-earnings ratio of 45.84 and currently yields dividends of 57.0%.
On 2026-02-28, Eli Lilly(LLY) stock moved within a range of $1,014.39 to $1,051.99. With shares now at $1,048.25, the stock is trading +3.3% above its intraday low and -0.4% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 4.33M, versus its average volume of 3.14M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Eli Lilly (LLY) is back in focus after fresh clinical data showed its injectable GLP-1 drug tirzepatide and oral candidate orforglipron outperforming Novo Nordi...
Eli Lilly (NYSE:LLY) reported that its oral GLP-1 candidate orforglipron outperformed Novo Nordisk’s oral semaglutide in a head to head Phase 3 trial in adults...
WSJ Heard on the Street columnist David Wainer breaks down why Novo Nordisk has struggled and Eli Lilly has prospered in the weight-loss drug market....
Analyst ratings
79%
of 34 ratingsMore LLY News
Innovent Biologics ( (HK:1801) ) just unveiled an update. Innovent Biologics announced that Jaypirca (pirtobrutinib), a highly selective non-covalent Bruton’s...
Drug giant Eli Lilly (LLY) and chip giant Nvidia (NVDA) opened LillyPod, the pharmaceutical industry’s most powerful supercomputer, in Indianapolis yesterday. T...
Key Points Novo Nordisk lost another head-to-head trial against Eli Lilly. The company is cutting prices on weight-loss drugs in 2026. The stock looks cheap,...
Eli Lilly and Co. (NYSE:LLY) shares are down on Thursday. The company announced promising results for its oral GLP-1 medication, orforglipron. On Thursday, the...
Eli Lilly's orforglipron, an oral GLP-1 therapy, outperformed oral semaglutide in the Phase 3 ACHIEVE-3 trial for adults with type 2 diabetes on metformin. The...
Eli Lilly (LLY) announced results from ACHIEVE-3, the first head-to-head Phase 3 trial evaluating the safety and efficacy of orforglipron, a small molecule oral...
Eli Lilly has seen revenue and earnings soar in recent years. One of the biggest growth markets in the pharmaceutical industry today is that of weight loss dru...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.